Linyi, Saint Helena

Guimin Zhang

This inventor holds 1 USPTO granted patent. Top assignee: Shandong New Time Pharmaceutical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guimin Zhang. Retrieved from https://idiyas.com/inventor/guimin-zhang-ldqm2e1t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guimin Zhang: Innovator in Bispecific Antibody Treatment

Introduction

Guimin Zhang is a notable inventor based in Linyi, Shandong, China. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. His innovative work aims to enhance treatment options for various medical conditions.

Latest Patents

Guimin Zhang holds a patent for a groundbreaking invention titled "Method of Treatment Using a Bispecific Antibody Binding BCMA and CD3." This patent represents a significant advancement in therapeutic strategies, potentially improving patient outcomes in targeted therapies.

Career Highlights

Zhang is currently associated with Shandong New Time Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical research and development. His work at the company focuses on innovative solutions in the healthcare sector, contributing to the advancement of medical treatments.

Collaborations

Throughout his career, Guimin Zhang has collaborated with talented professionals, including Xinlu Ma and Xingxia Hu. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Guimin Zhang's contributions to the field of biotechnology, particularly through his patent on bispecific antibodies, highlight his role as a key innovator in medical treatments. His work continues to inspire advancements in healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…